ArticleFrontiers in immunology2025

Efficacy and safety of first-line chemotherapy combined with immune checkpoint inhibitors for extensive-stage small cell lung cancer patients: a real-world propensity score matching study.

Bin Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.